Image

dTDI During a SBT to Predict Extubation Failure in Preterm Infants

dTDI During a SBT to Predict Extubation Failure in Preterm Infants

Recruiting
2-6 years
All
Phase N/A

Powered by AI

Overview

Weaning from mechanical ventilation is a critical issue and the diaphragmatic disfunction has been demonstrated to play an important role in extubation failure. the aim of present investigation is to evaluate diaphragmatic excursion velocity during in patients undergoing spontaneous breathing trial through tissue Doppler analysis in both inspiration and expiration.

Eligibility

Inclusion Criteria:

  • premature infants with gestational age <32 weeks and supported by invasive mechanical ventilation ≥48 hours
  • All the indications for extubation are met:cough or vomiting due to spontaneous breathing and sputum aspiration; ventilator parameters in recent 24 hours: MAP < 8cmH2O, RR < 30 times/min, FiO2 < 30%; Arterial blood gas: pH > 7.25, (PaCO2< 60mmHg, BE < 8mmol/L, oxygen saturation > 90%
  • a successful SBT
  • parents or legal guardians sign informed consent to attend this study

Exclusion Criteria:

  • accidental extubation
  • chest CT or bronchoscopy during hospitalization indicated congenital airway dysplasia
  • complex congenital heart disease
  • congenital metabolic diseases, neuromuscular diseases
  • severe brain injury
  • surgical mechanical ventilation
  • give up before extubation;
  • pneumothorax or pleural effusion
  • no consent is signed

Study details
    Premature

NCT05865977

Wang Jianhui

14 February 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.